CC
IMGN

Centiva Capital’s Immunogen Inc IMGN Stock Holding History

Centiva Capital’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-150,000
Closed -$4.45M – 2406
2023
Q4 		$4.45M Buy
+150,000
New +$2.99M 0.11% 178

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Centiva Capital's IMGN Position: Q1 2024 in Review

Centiva Capital sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 125,000 shares — an estimated $3.71M sold.

Centiva Capital first reported a position in IMGN in Q2 2023 and held it in 2 quarters. The position peaked at $3.71M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Centiva Capital reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Centiva Capital sold 125,000 Immunogen Inc shares in Q1 2024, an estimated $3.71M.
  • Centiva Capital first reported a position in Immunogen Inc in Q2 2023 and held it in 2 quarters.
  • Centiva Capital's Immunogen Inc position peaked at $3.71M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Centiva Capital's 13F filing for Q1 2024, filed 15 May 2024.